Document Type : original article


1 Exercise Physiology Department, Faculty of Physical Education and Sport Sciences, University of Tehran Alborz campus, Tehran, Iran

2 Exercise Physiology Department, Faculty of Physical Education and Sport Sciences, University of Tehran, Tehran, Iran


Background and Purpose: Alzheimer's disease (AD) is associated with decreases in neurons in several important areas for memory and learning in the brain, especially in the hippocampus. AD is a progressive brain disorder that causes gradual loss of memory, impaired learning ability, and connection problems with other people. Researchers have found that people with diabetes are 1.5 times more likely to develop AD. And suggests that Alzheimer's disease may indicate a specific type of diabetes in brain. Although this issue needs more research. Astrocytes are one of the most abundant types of glial cells that change and become hypertrophy in response to any damage to the central nervous system (CNS). An important feature of the glial reaction is the increased synthesis of GFAP protein, which is a protein that mediates cytoskeletal fibers and is the main determinant of the reactivation of astrocytes and cell damage. This phenomenon is known as the astrogliosis reaction and is one of the most common injuries in type 3 diabetes and AD. White matter changes in the hippocampus are one of the best biomarkers for recognizing the progression of Alzheimer's disease.
Materials and Methods: Twenty-five rats were randomly divided into five groups: 1-type 3 diabetes group (DM III), 2-healthy control group (Control), 3-type 3 diabetes and involuntary training (DM III + HIIT), 4-type 3 diabetes and voluntary activities in an enriched environment group (DM III + RE), and 5-the sham group (Sham). The activity method of the rats in the involuntary training group was performed as high intensity interval training and in accordance with the test of maximum training capacity by Wang et al. The rats of the voluntary training group were placed in the enriched environment for five days a week for two hours a day and simultaneously with the activity of the involuntary training group. GFAP was measured by DAB immunohistochemical method. Morris water maze test was used to evaluate spatial learning and memory of animals. Shapero-Wilk test was used to measure the normal distribution of data. One-way ANOVA and Tukey post-hoc test with a significance level of 5% was used to analyze the data. Statistical calculations were performed by GraphPad Prism software version 8, SPSS version 21, and Microsoft Excel software version 2010.
Results: The present study results showed that the type-3 diabetes control group had the highest amount of GFAP expression. This difference with all the research groups was statistically significant (P ≤ 0.05). The voluntary exercise group in the enriched environment and the involuntary exercise group had significantly lower GFAP than the type-3 diabetes control group. The voluntary exercise group had a lower GFAP expression percentage (23.67%) than the involuntary training group (26.01%). However, the difference between these two training groups was not statistically significant (P > 0.05). The Morris water maze test showed that the healthy control and sham groups spent more significant time in the target area and this difference was statistically significant only with the type-3 diabetes group (P ≤ 0.05). Both exercise groups spent more time in the target area than the type-3 diabetic group, but this difference was not statistically significant (P > 0.05). The voluntary exercise group spent more time in the target area and this group performed better in remembering information and spatial memory than the involuntary exercise group. Still, this difference was not statistically significant (P > 0.05).
Conclusion: Voluntary group activities in an enriched environment may have greater effects in reducing GFAP in the hippocampus white tissue of the diabetic type 3 rats. However, involuntary high-intensity interval training was also able to reduce the astrogliosis reaction compared to the diabetic type 3 control group. The voluntary exercise group in the enriched environment performed better in the Morris water maze test than the involuntary exercise group so the time spent in the target area quadrant by them was higher than the involuntary high-intensity exercise group.


  1. Gold CA, Budson AE. Memory loss in Alzheimer’s disease: Implications for development of therapeutics. Vol. 8, Expert Review of Neurotherapeutics. Expert Rev Neurother; 2008. p. 1879–91.
  2. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Vol. 377, The Lancet. Lancet Publishing Group; 2011. p. 1019–31.
  3. Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, et al. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging. 2010/06/08. 2010 Aug;31(8):1326–39.
  4. Kandimalla R, Thirumala V, Reddy PH. Is Alzheimer’s disease a Type 3 Diabetes? A critical appraisal. Biochim Biophys Acta - Mol Basis Dis. 2017;1863(5):1078–89.
  5. von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting. Vol. 524, Journal of Comparative Neurology. Wiley-Liss Inc.; 2016. p. 3865–95.
  6. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M. The Role of Astrocytes and Complement System in Neural Plasticity. Vol. 82, International Review of Neurobiology. 2007. p. 95–111.
  7. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17513–8.
  8. Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res. 1995 Mar 1;40(4):478–93.
  9. Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, Benali H, et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology. 2008 Jul;248(1):194–201.
  10. Rémy F, Vayssière N, Saint-Aubert L, Barbeau E, Pariente J. White matter disruption at the prodromal stage of Alzheimer’s disease: Relationships with hippocampal atrophy and episodic memory performance. NeuroImage Clin. 2015;7:482–92.
  11. Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22.
  12. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, et al. White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg & Psychiatry. 2002;72(6):742–6.
  13. Stoub TR, Detoledo-Morrell L, Dickerson BC. Parahippocampal white matter volume predicts Alzheimer’s disease risk in cognitively normal old adults. Neurobiol Aging. 2014 Aug;35(8):1855–61.
  14. Wang C, Stebbins GT, Medina DA, Shah RC, Bammer R, Moseley ME, et al. Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer’s disease. Neurobiol Aging. 2012 Jan;33(1):43–52.
  15. Association A. 2019 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2019 Mar 1;15(3):321–87.
  16. Mohammadi H, Avandi SM, Jamshidi M, Gooya M. Effect of eight weeks resistance training and ginger supplementation on glycosylated hemoglobin index in type 2 diabetes patients. Koomesh J. 2017;19(4). (In Persian).
  17. Rahmati MR, Kordi MR, Ravasi AA. Effect of six weeks forced and voluntary training before EAE induction on the expression of some adhesive molecules affecting the blood-brain barrier permeability. J Sport Exerc Physiol. 2022;15(1):57–68. (In Persian).
  18. Amrolahi Z, Avandi SM, Khaledi N. The effect of six weeks’ progressive resistance training on hippocampus BDNF gene expression and serum changes of TNF-α in diabetic wistar rats. J Sport Exerc Physiol. 2022;15(1):1–10. (In Persian).
  19. Naderi S, Habibi A, Kesmati M, Rezaie A, Ghanbarzadeh M. The Effects of Six Weeks High Intensity Interval Training on Amyloid Beta1-42 Peptide in Hippocampus of Rat Model of Alzheimer’s Disease Induced with STZ. J Clin Res Paramed Sci. 2018;In Press(In Press). )In Persian(.
  20. Beauquis J, Pavía P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V, et al. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice , model of Alzheimer ’ s disease. Exp Neurol. 2013;239:28–37.
  21. Wang N, Liu Y, Ma Y, Wen D. High-intensity interval versus moderate-intensity continuous training: Superior metabolic benefits in diet-induced obesity mice. Life Sci. 2017 Dec 15;191:122–31.
  22. COE. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Cets. 1991. p. 123.
  23. Ritschl LM, Fichter AM, Häberle S, von Bomhard A, Mitchell DA, Wolff K-D, et al. Ketamine-Xylazine Anesthesia in Rats: Intraperitoneal versus Intravenous Administration Using a Microsurgical Femoral Vein Access. J Reconstr Microsurg. 2015 Jun;31(5):343–7.
  24. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. J Alzheimers Dis. 2006 Mar;9(1):13–33.
  25. Grieb P. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism. Mol Neurobiol. 2016 Apr;53(3):1741–52.
  26. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: The revolution continues. Vol. 6, Nature Reviews Neuroscience. Nature Publishing Group; 2005. p. 626–40.
  27. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008 Nov;60(3):430–40.
  28. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta - Mol Basis Dis. 2017 May 1;1863(5):1037–45.
  29. The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI, 3rd edition. AJNR Am J Neuroradiol. 2005 Nov;26(10):2702.
  30. Yan Z, Gibson SA, Buckley JA, Qin H, Benveniste EN. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol. 2018;189:4–13.
  31. Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol. 2011;93(3):421–43.
  32. Bernardi C, Tramontina AC, Nardin P, Biasibetti R, Costa AP, Vizueti AF, et al. Treadmill exercise induces hippocampal astroglial alterations in rats. Neural Plast. 2013;2013.
  33. Li B, Liang F, Ding X, Yan Q, Zhao Y, Zhang X, et al. Interval and continuous exercise overcome memory deficits related to β-Amyloid accumulation through modulating mitochondrial dynamics. Behav Brain Res. 2019;376:112171.
  34. Nakano M, Kubota K, Hashizume S, Kobayashi E, Chikenji TS, Saito Y, et al. An enriched environment prevents cognitive impairment in an Alzheimer’s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus. Brain, Behav Immun - Heal. 2020;9:100149.

35.          Jankowsky J, Xu G, Fromholt D, Gonzales V, Borchelt D. Environmental Enrichment Exacerbates Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease. J Neuropathol Exp Neurol. 2004 Jan 1;62:1220–7.